Alife Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 19

Alife General Information

Description

Developer of an AI-based health technology designed to help people have healthy children. The company uses advancements in deep learning and software development technologies to help doctors select the healthiest embryos, enabling patients and future parents to improve their chances of a healthy pregnancy.

Contact Information

Website
www.alifehealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3717 Buchanan Street
  • Suite 400
  • San Francisco, CA 94123
  • United States
+1 (707)
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, FemTech
Corporate Office
  • 3717 Buchanan Street
  • Suite 400
  • San Francisco, CA 94123
  • United States
+1 (707)

Alife Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-Sep-2024 Completed Generating Revenue
4. Accelerator/Incubator 10-May-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Mar-2022 Completed Generating Revenue
2. Seed Round 12-Apr-2021 $9.5M $9.5M Completed Generating Revenue
1. Grant 16-Apr-2020 $75K Completed Generating Revenue
To view Alife’s complete valuation and funding history, request access »

Alife Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed-1
Seed 2,828,437 $0.000100 $2.83 $2.83 1x $2.83 13.96%
To view Alife’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Alife Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-based health technology designed to help people have healthy children. The company uses advancements
Other Healthcare Technology Systems
San Francisco, CA
44 As of 2023

Boston, MA
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alife Competitors (3)

One of Alife’s 3 competitors is Ovia Health, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ovia Health Formerly VC-backed Boston, MA
AIVF Venture Capital-Backed Tel Aviv, Israel
Kindara Formerly VC-backed Boulder, CO
You’re viewing 3 of 3 competitors. Get the full list »

Alife Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Alife Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240347182-A1 Methods for optimizing clinical embryology workload using artificial intelligence Pending 23-Mar-2023
AU-2022289837-A1 Machine learning for optimizing ovarian stimulation Pending 10-Jun-2021
AU-2022289837-A9 Machine learning for optimizing ovarian stimulation Pending 10-Jun-2021
CA-3208058-A1 Machine learning for optimizing ovarian stimulation Pending 10-Jun-2021
EP-4274594-A1 Machine learning for optimizing ovarian stimulation Pending 10-Jun-2021 G16H20/10
To view Alife’s complete patent history, request access »

Alife Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alife Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Freesolo Capital PE/Buyout Minority
Freya Ventures Venture Capital Minority
Angel (individual) Minority
Farvatn Venture Venture Capital Minority
Free Solo Ventures Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Alife FAQs

  • When was Alife founded?

    Alife was founded in 2020.

  • Where is Alife headquartered?

    Alife is headquartered in San Francisco, CA.

  • What is the size of Alife?

    Alife has 44 total employees.

  • What industry is Alife in?

    Alife’s primary industry is Other Healthcare Technology Systems.

  • Is Alife a private or public company?

    Alife is a Private company.

  • What is Alife’s current revenue?

    The current revenue for Alife is .

  • How much funding has Alife raised over time?

    Alife has raised $31.5M.

  • Who are Alife’s investors?

    Freesolo Capital, Freya Ventures, , Farvatn Venture, and Free Solo Ventures are 5 of 19 investors who have invested in Alife.

  • Who are Alife’s competitors?

    Ovia Health, AIVF, and Kindara are competitors of Alife.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »